Entera Bio Ltd. (ENTX)
NASDAQ: ENTX · Real-Time Price · USD
1.630
-0.010 (-0.61%)
Jul 14, 2026, 11:37 AM EDT - Market open
Entera Bio Market Cap
Entera Bio has a market cap or net worth of $80.34 million as of July 14, 2026. Its market cap has decreased by -10.73% in one year.
Market Cap
80.34M
Enterprise Value
77.15M
1-Year Change
-10.73%
Ranking
Category
Stock Price
$1.63
Market Cap Chart
Since June 28, 2018, Entera Bio's market cap has increased from $71.40M to $80.34M, an increase of 12.53%. That is a compound annual growth rate of 1.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 80.34M | -9.73% |
| Dec 31, 2025 | 89.00M | 13.96% |
| Dec 31, 2024 | 78.10M | 351.45% |
| Dec 29, 2023 | 17.30M | -17.62% |
| Dec 30, 2022 | 21.00M | -74.07% |
| Dec 31, 2021 | 81.00M | 309.09% |
| Dec 31, 2020 | 19.80M | -23.85% |
| Dec 31, 2019 | 26.00M | -25.50% |
| Dec 31, 2018 | 34.90M | -51.12% |
| Jun 28, 2018 | 71.40M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Telomir Pharmaceuticals | 85.28M |
| NeurAxis | 85.20M |
| Acrivon Therapeutics | 84.75M |
| Rein Therapeutics | 84.43M |
| Rallybio | 84.19M |
| Alps Group | 83.38M |
| OKYO Pharma | 81.34M |
| Champions Oncology | 80.68M |